Roll of Shwetkarveermooladi lepa in Dadru (skin Disease)

Phyto-Pharmacognostical study and clinical evaluation of Karveeradi Lepa in Dadru with special reference to Dermatophytosis. - SKL-D

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/054660

Enrollment

Registered

2023-07-03

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Duration of disease 2. Patient having age >12 years and 3. Patient having minimum 4 symptoms of Dadru will be included (Kandu, Raga, Pidaka, Utsanna Mandal)

Exclusion criteria

Exclusion criteria: 1. Patient having age 60 years will be excluded. 2. Uncontrolled Diabetes Mallitus, Cancer, AIDS, STD, T.B., and other disorder which leads to fatal condition for patients. 3. Other concomitant skin diseases occurring with Dadru or Dadru occurring as the complication of other diseases or allergic reaction of any other disease.

Design outcomes

Primary

Measure	Time frame
Reduction in symptoms like itching and pidika ( pappules par madal)Timepoint: 2 month	—

Secondary

Measure	Time frame
No of elevated circular patch and size of circular patches will be reduced and redness of skin will be reducedTimepoint: 3 month	—

Countries

India

Contacts

Public ContactDr Priyanka Jasani

Banaras Hindu University

drbhuwal@gmail.com7007593425

Outcome results